BIO-Key International Inc (BKYI) Stock Analysis
Verdict: AVOID
Middle East win provides temporary momentum, but a 7-month cash runway and ongoing share dilution make sustainable gains unlikely.
Investment score: 32/100
Analysis as of
Is BIO-Key International Inc stock worth reviewing? The TradeMates thesis
Despite a single-day rally of 71.52% driven by a Middle East government contract announcement, BIO-Key faces structural head-winds from a -$4.67M annual cash burn rate, an estimated 7-month cash runway, and ongoing share dilution.
7-factor investment score
- Valuation: 35/100 (weight 20%)
- Financial Health: 15/100 (weight 15%)
- Technical Momentum: 45/100 (weight 15%)
- Earnings Quality: 30/100 (weight 15%)
- Insider Sentiment: 40/100 (weight 10%)
- Analyst Consensus: 45/100 (weight 10%)
- Risk-Adjusted Return: 20/100 (weight 15%)
BIO-Key International Inc opportunities and risks
What speaks for BKYI
- Middle East government contract win expands international footprint.
What speaks against BKYI
- Severe cash burn creates an urgent financing runway wall.
Peers and competitors
- IDAI
- INTZ
- NBVA.V
- FALC
- AUID
- IVDA
- RDAR
- BWLK.V
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| BKYI | n/a | 0.4x | n/a | 81.7% | -50.0% | -135.3% |
| IDAI | n/a | 4.5x | n/a | 50.1% | -272.9% | -55.4% |
| INTZ | n/a | 2.6x | n/a | 73.1% | -191.2% | -68.5% |
| NBVA.V | n/a | 19.6x | n/a | 95.0% | -130.0% | -6.1% |
| FALC | 11.1x | 1.0x | 6.9x | 85.7% | 19.0% | -2.0% |
| AUID | n/a | 4.3x | n/a | 98.2% | -1450.4% | -246.2% |
| Peer median | n/a | 4.3x | n/a | 85.7% | -191.2% | -55.4% |
Frequently asked questions about BIO-Key International Inc (BKYI)
Is BKYI stock a good investment?
The TradeMates model rates BIO-Key International Inc as AVOID with an investment score of 32/100. Despite a single-day rally of 71.52% driven by a Middle East government contract announcement, BIO-Key faces structural head-winds from a -$4.67M annual cash burn rate, an estimated 7-month cash runway, and ongoing share dilution. This is algorithmic model output, not personal investment advice.
Is BKYI stock a buy?
The TradeMates model verdict for BKYI is AVOID with an investment score of 32/100. Treat this as a model signal to review, not a personal buy recommendation.